Bloomage Biotechnology Corp Stock Current Valuation
| 688363 Stock | 59.16 1.32 2.28% |
Valuation analysis of Bloomage Biotechnology helps investors to measure Bloomage Biotechnology's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At present, Bloomage Biotechnology's Cash is projected to increase significantly based on the last few years of reporting. The current year's Other Cashflows From Financing Activities is expected to grow to about 12 M, whereas Total Cashflows From Investing Activities is forecasted to decline to (935.4 M). Fundamental drivers impacting Bloomage Biotechnology's valuation include:
Price Book 4.06 | Enterprise Value 28.3 B | Enterprise Value Ebitda 52.804 | Price Sales 5.068 | Forward PE 41.3223 |
Overvalued
Today
Please note that Bloomage Biotechnology's price fluctuation is very steady at this time. Calculation of the real value of Bloomage Biotechnology is based on 3 months time horizon. Increasing Bloomage Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Bloomage Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bloomage Stock. However, Bloomage Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 59.16 | Real 51.19 | Hype 59.16 | Naive 54.37 |
The real value of Bloomage Stock, also known as its intrinsic value, is the underlying worth of Bloomage Biotechnology Company, which is reflected in its stock price. It is based on Bloomage Biotechnology's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bloomage Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bloomage Biotechnology Corp helps investors to forecast how Bloomage stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bloomage Biotechnology more accurately as focusing exclusively on Bloomage Biotechnology's fundamentals will not take into account other important factors: Bloomage Biotechnology Corp Company Current Valuation Analysis
Bloomage Biotechnology's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Bloomage Biotechnology Current Valuation | 28.26 B |
Most of Bloomage Biotechnology's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bloomage Biotechnology Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Bloomage Biotechnology Corp has a Current Valuation of 28.26 B. This is 147.66% higher than that of the Chemicals sector and 8.28% lower than that of the Materials industry. The current valuation for all China stocks is 69.97% lower than that of the firm.
Bloomage Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bloomage Biotechnology's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bloomage Biotechnology could also be used in its relative valuation, which is a method of valuing Bloomage Biotechnology by comparing valuation metrics of similar companies.Bloomage Biotechnology is currently under evaluation in current valuation category among its peers.
Bloomage Fundamentals
| Return On Equity | 0.062 | ||||
| Return On Asset | 0.0319 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 28.26 B | ||||
| Shares Outstanding | 481.68 M | ||||
| Shares Owned By Insiders | 61.00 % | ||||
| Shares Owned By Institutions | 16.58 % | ||||
| Price To Book | 4.06 X | ||||
| Price To Sales | 5.07 X | ||||
| Revenue | 6.08 B | ||||
| Gross Profit | 6.36 B | ||||
| EBITDA | 664.83 M | ||||
| Net Income | 592.56 M | ||||
| Total Debt | 153.13 M | ||||
| Book Value Per Share | 14.67 X | ||||
| Cash Flow From Operations | 699.65 M | ||||
| Earnings Per Share | 0.91 X | ||||
| Target Price | 56.46 | ||||
| Number Of Employees | 4.66 K | ||||
| Beta | 0.87 | ||||
| Market Capitalization | 29.04 B | ||||
| Total Asset | 8.47 B | ||||
| Retained Earnings | 2.45 B | ||||
| Working Capital | 1.9 B | ||||
| Net Asset | 8.47 B | ||||
| Last Dividend Paid | 0.38 |
About Bloomage Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bloomage Biotechnology Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bloomage Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bloomage Biotechnology Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Bloomage Stock
Bloomage Biotechnology financial ratios help investors to determine whether Bloomage Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bloomage with respect to the benefits of owning Bloomage Biotechnology security.